Does TADALAFIL Cause Hospitalisation? 469 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 469 reports of Hospitalisation have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 1.5% of all adverse event reports for TADALAFIL.
469
Reports of Hospitalisation with TADALAFIL
1.5%
of all TADALAFIL reports
26
Deaths
433
Hospitalizations
How Dangerous Is Hospitalisation From TADALAFIL?
Of the 469 reports, 26 (5.5%) resulted in death, 433 (92.3%) required hospitalization, and 6 (1.3%) were considered life-threatening.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 469 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which TADALAFIL Alternatives Have Lower Hospitalisation Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR